These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27310497)

  • 21. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BEAM Conditioning Regimen Has Higher Toxicity Compared With High-Dose Melphalan for Salvage Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma.
    Veeraputhiran M; Jain T; Deol A; Ayash L; Kim S; Dyson G; Bhutani D; Lum LG; Ratanatharathorn V; Uberti JP; Abidi MH
    Clin Lymphoma Myeloma Leuk; 2015 Sep; 15(9):531-5. PubMed ID: 26166312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens.
    Burt RK; Marmont A; Oyama Y; Slavin S; Arnold R; Hiepe F; Fassas A; Snowden J; Schuening F; Myint H; Patel DD; Collier D; Heslop H; Krance R; Statkute L; Verda L; Traynor A; Kozak T; Hintzen RQ; Rose JW; Voltarelli J; Loh Y; Territo M; Cohen BA; Craig RM; Varga J; Barr WG
    Arthritis Rheum; 2006 Dec; 54(12):3750-60. PubMed ID: 17133541
    [No Abstract]   [Full Text] [Related]  

  • 25. Phase I/II study of bortezomib-BEAM and autologous hematopoietic stem cell transplantation for relapsed indolent non-Hodgkin lymphoma, transformed, or mantle cell lymphoma.
    William BM; Allen MS; Loberiza FR; Bociek RG; Bierman PJ; Armitage JO; Vose JM
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):536-42. PubMed ID: 24434781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autologous stem cell transplantation for autoimmune diseases: issues in protocol development.
    McSweeney PA; Nash RA; Storb R; Furst DE; Gauthier J; Sullivan KM
    J Rheumatol Suppl; 1997 May; 48():79-84. PubMed ID: 9150124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.
    Saccardi R; Kozak T; Bocelli-Tyndall C; Fassas A; Kazis A; Havrdova E; Carreras E; Saiz A; Löwenberg B; te Boekhorst PA; Gualandio F; Openshaw H; Longo G; Pagliai F; Massacesi L; Deconink E; Ouyang J; Nagore FJ; Besalduch J; Lisukov IA; Bonini A; Merelli E; Slavino S; Gratwohl A; Passweg J; Tyndall A; Steck AJ; Andolina M; Capobianco M; Martin JL; Lugaresi A; Meucci G; Sáez RA; Clark RE; Fernandez MN; Fouillard L; Herstenstein B; Koza V; Cocco E; Baurmann H; Mancardi GL;
    Mult Scler; 2006 Dec; 12(6):814-23. PubMed ID: 17263012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
    Kashyap A; Snowden J
    J Rheumatol Suppl; 2001 Oct; 64():39-41. PubMed ID: 11642503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma.
    Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V
    Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch.
    Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of hematopoietic stem cell transplant in Shiraz: 15 years experience in southern Iran.
    Ramzi M; Nourani H; Zakerinia M; Dehghani M; Vojdani R; Haghshenas M
    Exp Clin Transplant; 2010 Mar; 8(1):61-5. PubMed ID: 20199373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
    Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
    Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune disease after autologous hematopoietic stem cell transplantation.
    Bohgaki T; Atsumi T; Koike T
    Autoimmun Rev; 2008 Jan; 7(3):198-203. PubMed ID: 18190878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC].
    Bonnin A; Terriou L; Beuvon C; Tudesq JJ; Puyade M; Pugnet G; Maria A; Llorente CC; Lansiaux P; Cacciatore C; Badoglio M; Yakoub-Agha I; Farge-Bancel D; Marjanovic Z
    Bull Cancer; 2024 Feb; 111(2S):S84-S95. PubMed ID: 37845095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
    Gkotzamanidou M; Papadimitriou CA
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicity.
    Kim JE; Lee DH; Yoo C; Kim S; Kim SW; Lee JS; Park CJ; Huh J; Suh C
    Leuk Res; 2011 Feb; 35(2):183-7. PubMed ID: 20684990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
    Wang EH; Chen YA; Corringham S; Bashey A; Holman P; Ball ED; Carrier E
    Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.
    Leger C; Sabloff M; McDiarmid S; Bence-Bruckler I; Atkins H; Bredeson C; Zhang H; Huebsch L
    Ann Hematol; 2006 Oct; 85(10):723-9. PubMed ID: 16832675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease.
    Rabusin M; Andolina M; Maximova N; Lepore L; Parco S; Tuveri G; Jankovic G
    Haematologica; 2000 Nov; 85(11 Suppl):81-5. PubMed ID: 11268330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study.
    Tribalto M; Amadori S; Cudillo L; Caravita T; Del Poeta G; Meloni G; Avvisati G; Petrucci MT; Pulsoni A; Leone G; Sica S; Martelli M; Tabilio A; Fioritoni G; Majolino I; Mandelli F
    Haematologica; 2000 Jan; 85(1):52-8. PubMed ID: 10629592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.